KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- April 16, 2007 -- Sernova Corp. (TSX VENTURE: SVA) is pleased to announce the peer reviewed, scientific publication of a Sertoli cell study on humans, co-authored by Dr. David White, Sernova’s principal researcher and Novartis/Stiller Chair of Xenotransplantation at the University of Western Ontario. The study is published in the March 2007 issue of The Journal of Clinical Immunology.
